Abstract
ATP-binding cassette (ABC) is one of the two major superfamilies of transporters present across the evolutionary scale. ABC superfamily members came to prominence due to their ability to extrude broad spectrum of substrates and to confer multi drug resistance (MDR). Overexpression of some ABC transporters in clinical isolates of Candida species was attributed to the development of MDR phenotypes. Among Candida species, Candida glabrata is an emerging drug resistant species in human fungal infections. A comprehensive analysis of such proteins in C. glabrata is required to untangle their role not only in MDR but also in other biological processes. Bioinformatic analysis of proteins encoded by genome of human pathogenic yeast C. glabrata identified 25 putative ABC protein coding genes. On the basis of phylogenetic analysis, domain organization and nomenclature adopted by the Human Genome Organization (HUGO) scheme, these proteins were categorized into six subfamilies such as Pleiotropic Drug Resistance (PDR)/ABCG, Multi Drug Resistance (MDR)/ABCB, Multi Drug Resistance associated Protein (MRP)/ABCC, Adrenoleukodystrophy protein (ALDp)/ABCD, RNase L Inhibitor (RLI)/ABCE and Elongation Factor 3 (EF3)/ABCF. Among these, only 18 ABC proteins contained transmembrane domains (TMDs) and were grouped as membrane proteins, predominantly belonging to PDR, MDR, MRP, and ALDp subfamilies. A comparative phylogenetic analysis of these ABC proteins with other yeast species revealed their orthologous relationship and pointed towards their conserved functions. Quantitative real time PCR (qRT-PCR) analysis of putative membrane localized ABC protein encoding genes of C. glabrata confirmed their basal expression and showed variable transcriptional response towards antimycotic drugs. This study presents first comprehensive overview of ABC superfamily proteins of a human fungal pathogen C. glabrata, which is expected to provide an important platform for in depth analysis of their physiological relevance in cellular processes and drug resistance.
Introduction
ABC superfamily also known as ‘Traffic ATPases’ is very diverse and well-studied family of proteins known to exist from prokaryotes to higher eukaryotes [1]. These proteins are well known for their role as high affinity nutrient importers in bacterial cells and rose to prominence as exporters in higher eukaryotes. ABC proteins are promiscuous translocator of wide range of substrates such as sugars, amino acids, ions, peptides, cholesterol, metabolites, and toxins across the biological membranes, which are powered by ATP hydrolysis [2]. These proteins are known to perform diverse functions and their ability to confer MDR brought them to eminence. Typically, a full ABC transporter consists of four distinct domains: two TMDs consisting of six transmembrane helices (TMHs) and two nucleotide binding domains (NBD), located on the cytosolic side of the membrane [3]. The NBDs, which couple energy of ATP hydrolysis to power drug export are highly conserved structure [4]. Each NBD contains three characteristic motifs: Walker A and Walker B motifs, which form the nucleotide-binding site, and an ABC signature sequence, or C motif, for which several functions have been proposed, including communication between the TMDs and NBDs during the transport cycle [5,6]. The conserved sequence motifs Walker A and Walker B are separated by approximately 120 amino acids residues and the signature sequence is placed between these two motifs [7]. TMDs on the other hand with its homo- or heteromeric repeats of unrelated TMHs provide three dimensional structures for substrate binding and help in transport process [8]. In contrast to NBDs which consist of conserved sub-domains, TMHs of two TMDs are of variable structure which imparts poly specificity to these transporters [9]. While two NBDs and two TMDs are required to become a full functional ABC transporter, half ABC transporters also known to exist with one each of NBD and TMD and presumably function as homo-dimers [10]. The eukaryotic ABC superfamily is classified into nine subfamilies (A to I), according to the HUGO nomenclature [11]. The newly added ABC subfamily ABCI (the prokaryotic type ABC protein subfamily) contains ABC proteins without NBD, and is confined to plant taxa [12]. ABCH subfamily is identified in the genomes of arthropods but is absent in most of the plants, animals and fungal genomes [13]. Subfamily ABCA is known to exist in animal, plant and various protists but is absent in yeast genome [14].
Saccharomyces cerevisiae and Candida albicans possess a battery of ABC proteins, which are reasonably well characterized for their role in MDR [7,15]. However, such information is lacking for an emerging pathogenic haploid yeast C. glabrata. Recent epidemiological data revealed that C. glabrata is the second most frequently isolated nosocomial species among fungal infections [16], and exist as a commensal of normal microbiota of oral cavity, gastrointestinal and genital tract in humans [17]. Notably, C. glabrata is phylogenetically distant from pathogenic C. albicans and closer to nonpathogenic yeast S. cerevisiae [18]. The clinical isolates of C. glabrata show high level of resistance towards commonly used antifungal such as azoles [19]. MDR, the acquisition of resistance towards various classes of antifungal drugs is a serious clinical challenge for candidiasis treatment. Recently, high attention was derived by ABC proteins of C. glabrata due to the fact that some of the efflux pumps encoding genes such as CAGL0M01760g (CgCDR1), CAGL0F02717g (CgPDH1) and CAGL0I04862g (CgSNQ2) are highly expressed in clinical isolates of C. glabrata and contribute to the development of azole resistance [20–24]. Earlier, CAGL0M01760g (CgCDR1) and CAGL0F02717g (CgPDH1) upregulation independent of CgPDR1 mutation in fluconazole heteroresistant C. glabrata clinical isolates has been also reported [25]. Therefore, an in depth analysis of large members of ABC superfamily of C. glabrata is required to dissect their physiological relevance in MDR and other cellular processes.
This study represents the identification and phylogenetic analysis of proteins belonging to ABC superfamily of C. glabrata. Our analysis identified 25 putative ABC proteins, among them 18 members possesses at least one each of NBD and TMD and categorized as ABC transporters. The remaining 7 possess only NBDs, hence are grouped as soluble ABC proteins. Basal expression analysis of all ABC transporters revealed that all coding sequences were transcribed under normal laboratory conditions. Transient treatment with antimycotic drugs leads to the differential expression of some ABC transporters, implying their potential role in development of MDR. The phylogenetic analysis and expression profiles presented here will pave the way for future investigations involving molecular and biological significance of ABC transporters in pathogenic yeast C. glabrata.
Materials and methods
Identification and sequence retrieval
C. glabrata genome sequences were downloaded from the NCBI genome database (ftp.ncbi.nlm.nih.gov/genomes) with assembly no. ASM254v2. ABC proteins were identified by using the model ABC-tran (accession PF00005) of the Pfam database (https://pfam.xfam.org/) and the HMM search program from the HMMER package (http://hmmer.org/) using the default settings. Positive hits above the default threshold were further filtered by a cutoff, defined from the plot of scores and e-values (S1 Fig). Hits with domain score greater than 56.4 and e-value less than 1.2e-20 were considered true positives containing the NBD domain and extracted as potential ABC sequences for further analysis (Table 1).
Table 1. Predicted ABC proteins in C. glabrata.
RefSeq ID | ORF Name | Gene names* | Length# | UniProt Entry |
---|---|---|---|---|
XP_448240.1 | CAGL0K00363g | 1227 | Q6FNF4 | |
XP_444820.1 | CAGL0A01133g | 801 | Q6FXW2 | |
XP_449941.1 | CAGL0M13739g | ATM1 | 727 | Q6FIK3 |
XP_445704.1 | CAGL0E00385g | 608 | Q6FVP0 | |
XP_445860.1 | CAGL0E03982g | 1659 | Q6FV84 | |
XP_445319.1 | CAGL0C03289g | YBT1 | 1648 | Q6FWS5 |
XP_445834.1 | CAGL0E03355g | 1535 | Q6FVB0 | |
XP_449053.1 | CAGL0L06402g | YCF1 | 1535 | Q6FL41 |
XP_446375.1 | CAGL0G00242g | YOR1 | 1477 | Q6FTR9 |
XP_445428.1 | CAGL0D00352g | 861 | Q6FWG6 | |
XP_449450.1 | CAGL0M02387g | 856 | Q6FJZ4 | |
XP_446712.1 | CAGL0G08041g | 607 | Q6FST2 | |
XP_445278.2 | CAGL0C02343g | ARB1 | 720 | Q6FWW6 |
XP_445575.1 | CAGL0D03674g | 1186 | Q6FW19 | |
XP_448674.1 | CAGL0K10472g | 752 | Q6FM70 | |
XP_445123.1 | CAGL0B03487g | TEF3 | 1045 | O93796 |
XP_447598.1 | CAGL0I08019g | 1285 | Q6FQ96 | |
XP_449421.1 | CAGL0M01760g | CDR1 | 1499 | Q6FK23 |
XP_447461.1 | CAGL0I04862g | SNQ2 | 1507 | Q6FQN3 |
XP_446088.1 | CAGL0F02717g | PDH1/CGR1 | 1542 | O74208 |
XP_449665.1 | CAGL0M07293g | 1515 | Q6FJC9 | |
XP_446033.1 | CAGL0F01419g | AUS1 | 1398 | Q6FUR1 |
XP_449114.1 | CAGL0L07744g | 1055 | Q6FKY0 | |
XP_446582.1 | CAGL0G05093g | 544 | Q6FT62 | |
XP_448758.1 | CAGL0K12474g | 294 | Q6FLY6 |
* Name of genes given in the NCBI database
# Length of proteins in amino acids
Multiple sequence alignment and phylogenetic analysis
Amino acid sequences of C. glabrata NBDs (accession PF00005) were extracted as per their locations in the ABC proteins and S. cerevisiae NBD sequences of ABC proteins were retrieved by UniProt (www.uniprot.org/). The complete amino acid sequences of ABC proteins of S. cerevisiae, C. albicans, Cryptococcus neoformans, Kleyvuromyces lactis and Schizosaccharomyces pombe were taken from previously published report [14]. ITS sequences were taken from online database SILVA (https://www.arb-silva.de/). Sequences were aligned by ClustalW with default parameters and phylogenetic trees were generated by MEGA6.06 using maximum likelihood (ML) method and poisson amino acid substitution model with 1000 bootstrap replications. Sequence identities of ABC proteins among different species were analyzed by using BLASTp (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins) with default parameters.
Topology, Chromosomal location, and localization prediction of ABC proteins
The topology of C. glabrata ABC proteins was predicted by online softwares Scan Prosite (http://prosite.expasy.org/scanprosite/) and Topocons (http://topcons.cbr.su.se/). Scan Prosite was used to recognize the NBD location and Topocons was utilized for TMH identification. Size and chromosomal location of the ABC proteins were retrieved from the Candida Genome Database (http://www.candidagenome.org/) and a circular ideogram was generated by using Circos software (http://circos.ca/software/). To predict subcellular localization of ABC proteins, LocTree3 (https://rostlab.org/services/loctree2/) and WoLF PSORT (https://www.genscript.com/wolf-psort.html) were employed with input of putative ABC proteins amino acid sequences.
Strain and Chemicals
Two C. glabrata strains reference strain CBS138/ATCC2001 and BG2, gifted by New Jersey Medical School–Rutgers, Newark, New Jersey and Lab of fungal pathogenesis, CDFD, Hyderabad, India respectively, were used in present study. Yeast cultures were maintained in YPD broth (2% peptone, 1% yeast extract and 2% glucose) and YPD Agar (YPD broth with 2% agar). Antifungal drugs (fluconazole, amphotericin B, caspofungin and ketoconazole) were of analytical grade and purchased from Sigma Aldrich, India.
Total RNA isolation and cDNA synthesis
Total RNA was extracted by using RNeasy Mini Kit (QIAGEN, Germany) using prescribed protocol. Briefly, overnight grown cultures of C. glabrata were diluted to 0.1 OD600 and grown for 4 hrs. at 30°C in YPD, followed by 60 minutes treatment with desired drugs (fluconazole, 16μg/ml; amphotericin B, 1μg/ml; caspofungin, 75ng/ml and ketoconazole, 0.5μg/ml) concentration as per MIC50 values. Cells were washed with PBS and total RNA was extracted as per the manufacturer’s protocol. RNA samples were quantified using nanodrop 2000 spectrophotometer (Thermo Scientific, USA) and 5μg of total RNA was used for cDNA synthesis by using RevertAid H minus first strand cDNA synthesis kit (Thermo Scientific, Lithuania).
Quantitative real-time PCR
Quantitative gene expression profile was evaluated by using DyNAmo Flash SYBR Green qPCR kit (Thermo Scientific, Lithuania) and gene-specific primers (Table 2) including CAGL0G09383g (CgTDH3) for normalization in CFX96TM real time PCR system (Bio-Rad, USA). CgTDH3 gene was used as reference gene because its expression was constant in presence of all tested conditions (data not shown). The basal expression level of ABC transporters was measured by comparing the Ct value of the gene with CgTDH3. Comparative expression profiles of ABC transporters in drug-treated versus untreated conditions were analyzed by 2-ΔΔCt method [26]. qRT-PCR was performed in biological duplicate with technical triplicate.
Table 2. Primers used in this study.
ABC Gene ORF | Forward primers (5’ - 3’) | Reverse primers (5’ - 3’) |
---|---|---|
CAGL0G09383g | CCACGGTAGATACGCTGGTG | CAGAACCCCATGGCAAGTTAGC |
CAGL0F02717g | CTTTATATGAGGCAAGACC | GAAGTTCACCAGGAAATAG |
CAGL0F01419g | GTCACCATACACTTACTTC | CAACCATCCACCATATTC |
CAGL0M01760g | TGATGGCTGTAAGACTATG | TCCATACTTCGTGGTAATC |
CAGL0I04862g | GATCCAGGTGACTCTTATAC | GGATTCCCTTACCTCAAATA |
CAGL0I08019g | CTTTAATGGATCACCAGAG | CTGGTCTTAGAGTGTATTTC |
CAGL0M07293g | CACGATAAGAAGGTTGTATG | CACTATATGGGCAGTAGTT |
CAGL0L07744g | CGAAATTCCTGGGTATAAG | GGTGATTGAGACACATAC |
CAGL0G00242g | TCTTACGTGCTCTTACTC | CCATTAGTAGGCCAATTATC |
CAGL0L06402g | CCTCTTCTACTGGTGATATTG | CCCACATAGAATGACCTAAA |
CAGL0C03289g | GTCGACTATGACAAGATTC | ATCCAACTCTCCACTATC |
CAGL0E03982g | CTCTCACGTATGCTATTTC | AGTAGTGATAGTACCTTCG |
CAGL0E03355g | CACAGGAAGGAAACTATG | GAGAGAGCATCTTCTAGT |
CAGL0D00352g | GGTGTTCAGCAAAGATTAG | CAGACAGATATAACCGAGAT |
CAGL0M02387g | CCTCCCAGCTATTCTATTC | CTAGTCTTGCGACAAATAAG |
CAGL0A01133g | CTAAGAGTCCTAAGTGAAAG | GAACGAGATACCACATAAG |
CAGL0M13739g | CTGTACCTCTGAACTTCT | CCATCACTCTTGCTTATAC |
CAGL0E00385g | GGGTTACCTATCACATTC | GACCCAGTCCTATAATAAC |
CAGL0K00363g | CCAACACTATTCAACGATAC | TTCCACCAGAACCTATTC |
Statistical analysis
The statistical analysis was performed by GraphPad Prism 6. Data obtained were expressed as means ± SDs. The significance of differences between control and experimental groups were analyzed by using two-way ANOVA and statistical significant differences relative to untreated condition (YPD) were determined by Sidak's multiple comparisons test with p value <0.0001.
Results and discussion
Identification of ABC proteins in C. glabrata
To investigate putative ABC proteins, the HMM profile of the ABC transporter domain (accession PF00005) was utilized as the queries to search against 5213 protein coding ORFs in C. glabrata genome. Initially, a total of 54 proteins consisting NBD domain in the range of 150±20 amino acids were found. Since, NBD is a member of the Rossman fold superfamily of nucleotide binding proteins, and to ensure that only NBD containing proteins are detected, a threshold was determined from the plot of domain scores and e-values (S1 Fig), and a large inflection at a score of 56.4 and e-value of 1.2 e-20 was observed. Further, examination of sequences below this score and with a higher e-value showed that canonical motifs associated with NBD were absent in 29, out of these 54 proteins. Hence, only 25 proteins with higher score and lower e-value than the set threshold were considered for further study (Table 1).
Phylogenetic analysis, domain organization and subfamily prediction
The complete genome sequence and phylogenetic analysis of S. cerevisiae and C. albicans identified 30 and 26 distinct ABC protein encoding genes, respectively [27]. Considering close phylogenetic similarity of C. glabrata with S. cerevisiae and to predict subfamilies, an unrooted phylogenetic tree was constructed by aligning NBDs of C. glabrata and S. cerevisiae ABC proteins as described in methods. Based on resemblance in domain organization with S. cerevisiae, putative ABC proteins of C. glabrata were segregated into six major clusters and were assigned to MDR/ABCB, MRP/ABCC, ALDp/ABCD, RLI/ABCE, EF3/ABCF and PDR/ABCG subfamilies (Fig 1). The domain organization of C. glabrata ABC proteins was consistent with that of S. cerevisiae in ML tree, wherein N- and C- terminal NBDs are segregated separately; indicating that full transporters could be the outcome of duplication of half transporters.
To attain a better understanding of evolutionary relationship in ABC proteins among yeast species another phylogenetic tree was constructed by using complete ABC proteins of six representative yeast species (S. cerevisiae, C. albicans, C. neoformans, K. lactis and S. pombe) including C. glabrata (Fig 2A). Among them, S. pombe possess the least member of ABC proteins (19 ABC proteins) while C. neoformans has maximum (33 ABC proteins) ABC protein members (Fig 2B). Notably, S. pombe was distinct with regard to a number of subfamilies since it does not have any member protein belonging to ALDp/ABCD subfamily. Our analysis further revealed that phylogenetically C. glabrata ABC subfamily proteins are closer to S. cerevisiae and K. lactis ABC proteins. Interestingly, in addition to the NBD, members of each family also have conserved amino acid sequences, which could help in providing a comparative evolutionary orthologous relationship among various yeast species. Considering almost similar size of C. glabrata (12.3Mb) and S. cerevisiae (12.1Mb) genome, it is notable that the former possess lesser number of ABC proteins, which could suggest loss of some of the genes during whole genome duplication (WGD) event [28]. In S. cerevisiae and C. glabrata ABCG/PDR family forms the largest subfamily, although it has significantly lower number in C. glabrata. Among subfamilies, preferentially MDR/ABCB, ALDp/ABCD and RLI/ABCE family members were retained during duplication event, indicating their significance in cell physiology.
ABC proteins have two characteristic topological structures: TMD and NBD. The presence of hydrophobic TMD in the protein makes it an eligible candidate of membrane-localized proteins, while presence of only NBD makes it a putative soluble protein. To investigate whether C. glabrata ABC proteins follow the same domain organization as reported in other organisms, the position of NBDs and TMDs were determined in each of the ABC protein sequences by using Topocons and Scan Prosite. Based on the order of NBDs and TMDs, the ABC proteins belonging to the subfamilies ABCB/MDR, ABCC/MRP, ABCD/ALDp were predicted to possess forward topology, wherein TMD precedes the NBD (TMD-NBD), while the members of ABCG/PDR subfamily have reverse orientation, where TMD follows NBD (NBD-TMD) [29] (Fig 3). A typical TMD is comprised of 6 to 10 TMHs [30], however the prediction with different topology predicting softwares indicated the presence of a variable number of TMH in ABC proteins containing TMDs (S1 File). All the proteins with only NBDs in primary structure belong to ABCE/RLI and ABCF/EF3 subfamilies and were predicted as soluble proteins.
Multi drug resistance (MDR)/ABCB subfamily
The MDR subfamily members comprise of both full and half transporters with forward topology, (TMD-NBD)2 or (TMD-NBD). ABCB1 was the first characterized member of MDR subfamily for its ability to confer MDR in mammalian cells [1]. This subfamily is further divided into three subtypes: full transporters (involved in MDR), half transporters (involved in the transportation of peptides) and mitochondrial half membrane transporters [31]. Four ABC proteins of C. glabrata CAGL0K00363g, CAGL0E00385g, CAGL0M13739g (CgATM1), and CAGL0A01133g belong to MDR subfamily but are remain to be characterized (Fig 1). Among these CAGL0K00363g, the only member of MDR/ABCB full transporter in C. glabrata, was clustered with similar full transporters in other yeasts. It showed 42% sequence identity with S. cerevisiae haploid-specific ABC transporter STE6, the a-factor pheromone transporter [32]. The three half transporters CAGL0M13739g (CgATM1), CAGL0A01133g, and CAGL0E00385g showed an orthologous relationship with S. cerevisiae mitochondrial half transporters. CAGL0M13739g (CgATM1) is ortholog of an inner mitochondrial membrane-localized transporters of S. cerevisiae (ATM1), which translocate iron-sulfur (Fe/S) clusters into the cytosol [33] and has a well-defined mitochondrial targeting signal sequence. Biogenesis of iron-sulfur (Fe/S) clusters as a function of ATM1 is highly conserved among various fungal species [14]. In C. glabrata, CAGL0M13739g (CgATM1) is involved in osmosensitivity and echinocandin sensitivity [34]. CAGL0E00385g and CAGL0A01133g are orthologs of peptide transporter MDL1 and MDL2, respectively, of S. cerevisiae localized in the mitochondrial inner membrane [35].
Multi drug resistance associated proteins (MRP)/ABCC subfamily
None of the ABC proteins of this subfamily are characterized in C. glabrata. MRP subfamily members belonging to mammalian cells and other major groups of eukaryotes are known to efflux diverse array of toxic substrates including drugs and xenobiotics compounds outside the cell or sequester into the vacuole [36]. The unique feature of this family is to recognize glutathione (GSH)-, glucuronate- and sulfate- conjugated organic anions and are involved in detoxification processes [37]. It has also been observed that MRPs synergistically act with a large number of enzymes viz, GSH-S-transferase, UDP- glycosyltransferase to contribute resistance towards various substrates [38]. Notably, unlike MDR or PDR subfamilies, all the MRP members exist as full transporters. Five putative ABC proteins of C. glabrata were clustered into this group, among them CAGL0E03982g, CAGL0C03289g (CgYBT1), CAGL0E03355g, and CAGL0L06402g (CgYCF1) have an extra transmembrane region TMD0(TMD- NBD)2 and were considered as long MRPs, and CAGL0G00242g (CgYOR1) has topology of (TMD- NBD)2, considered to be short MRP (Fig 3). C. glabrata MRP members showed phylogenetic similarity with K. lactis and S. cerevisiae ABC proteins. However, CAGL0G00242g (CgYOR1) have 71% sequence identity with S. cerevisiae YOR1, a well-studied plasma membrane localized transporter involved in transport of various organic anions including oligomycin and phospholipids [39]. CAGL0G00242g (CgYOR1) also exhibited 31% sequence identity with the only known channel human CFTR/ABCC7 in the ABC transporter superfamily protein, where mutations in its encoding gene sequence were linked to cystic fibrosis [40]. CAGL0C03289g (CgYBT1) has a sequence identity of 53% with S. cerevisiae YBT1. CAGL0G00242g (CgYOR1) and CAGL0C03289g (CgYBT1), both were found to be upregulated in azole resistant lab mutant as well as in azole resistant clinical isolates [41,42]. 42% sequence identity of CAGL0L06402g (CgYCF1) was observed with human MRP1 which is involved in endobiotics and xenobiotics extrusion [43]. Previous report also suggested the upregulation of CAGL0L06402g (CgYCF1), CAGL0C03289g (CgYBT1) and CAGL0G00242g (CgYOR1) in the petite strain isolates [44].
Adrenoleukodystrophy protein (ALDp)/ABCD)
ALDp/ABCD subfamily proteins found in all eukaryotic organisms with an exception to some plants predominantly exist as half transporters [45]. Half ALDp members homogenously or heterogeneously dimerize to become functional [46]. In C. glabrata CAGL0M02387g and CAGL0D00352g belong to this subfamily which showed orthology with S. cerevisiae PXA1 and PXA2, respectively. ALDps are peroxisomal membrane localized proteins in S. cerevisiae, involved in long and branched chain fatty acids import or their conjugate fatty acyl-CoA derivatives transport to peroxisome [47]. Interestingly, mutations in either PXA1 or PXA2 make cells incompetent to grow on oleic acid, suggesting that probably they function as a heterodimer [48]. Moreover, both ALDps of C. glabrata such as CAGL0M02387g and CAGL0D00352g, showed 32% and 33% sequence identity with human ABCD2 and 31% and 32% identity with ABCD1. The human ABCD1 and ABCD2 are involved in translocation of polyunsaturated VLCFA-CoA and mutation in these genes result in a human disease, X-linked Adrenoleukodystrophy (X-ALD) [49]. The clear evolutionary orthologous relationship between this family members in various species strongly point to their conserved functions.
RNase L Inhibitor (RLI)/ABCE subfamily
The RLI/ABCE subfamily proteins have a characteristic pair of linked NBDs with no TMDs. These soluble proteins are predicted to have a role in biological processes rather than in membrane transport [50]. In human ABCE1, an RLI protein is associated with polyribosomes and functions to inhibit RNase L to initiate translation [51]. CAGL0G08041g, the only member of this family in C. glabrata, displayed NBD-NBD topology and has a characteristic ferredoxin iron-sulfur type binding domain (4Fe-4S) with the consensus sequence of C-X-{P}-C-X(2)-C-{CP}-X(2)-C-[PEG], (pfam00037, where four C’s are the 4Fe-4S center) which is a typical motif found in nucleic acid binding proteins. CAGL0G08041g showed high sequence identity with S. cerevisiae RLI1 (89%) and K. lactis KLLA0C17556p (88%). RLI1 of S. cerevisiae, an iron-sulfur (4Fe-4S) protein, is involved in maturation of ribosomal subunit, translation initiation through interaction with eIF3 complex and also have a role in translational termination [52], however, this protein remains uncharacterized in C. glabrata.
Elongation factor 3 (EF3)/ABCF subfamilies
The members of this subfamily are topologically similar to RLI subfamily proteins with paired NBDs without TMDs. In human and yeast species, EF3 is involved in several aspects of translation such as ribosome biogenesis, translational control of gene expression, exporting mRNA into cytoplasm, or act as a translational elongation factor [14]. A total of four members namely, CAGL0K10472g, CAGL0C02343g, CAGL0D03674g, and CAGL0B03487g (CgTEF3) of ABC proteins in C. glabrata belonged to this subfamily. CAGL0B03487g (CgTEF3) and CAGL0C02343g showed 88% and 90% sequence identity with S. cerevisiae TEF3 and ARB1, respectively. In C. glabrata, CAGL0B03487g (CgTEF3) is an essential gene for growth and at protein level, it has been reported to be down regulated at alkaline pH [53,54]. The best characterized member of this subfamily in S. cerevisiae is GCN20, which mediates the activation of eIF-2α kinase [55] and showed 89% sequence identity with CAGL0K10472g. All members of this family are remain uncharacterized in C. glabrata.
Pleiotropic Drug Resistance (PDR)/ABCG subfamily
PDR/ABCG subfamily is ubiquitous throughout the plants, fungi and animal kingdom but absent in bacteria. In animals, PDR subfamily members exist as half transporters and are homologous to the white-brown-complex (WBC) family transporter of Drosophila. In previous report, it is suggested that there could be two possibilities of generation of PDR/ABCG subfamily, 1) by fusion of independent NBD and TMD, because it is the only subfamily in which NBD precedes the TMD (reverse topology) or 2) by direct origin from the central portion of a member of the ABCA, ABCB, or ABCC subfamilies [56]. Notably, PDR/ABCG subfamily members play important roles in extruding a variety of xenobiotics including agricultural fungicides, azoles, mycotoxins, herbicides, and antifungal drugs [57]. Similar to S. cerevisiae and C. albicans, PDR/ABCG subfamily with 7 members; CAGL0F02717g (CgPDH1), CAGL0F01419g (CgAUS1), CAGL0M01760g (CgCDR1), CAGL0I04862g (CgSNQ2), CAGL0I08019g, CAGL0M07293g, and CAGL0L07744g represents the largest group in C. glabrata wherein, all the members except CAGL0L07744g are full transporters. Importantly, CAGL0M01760g (CgCDR1), CAGL0I04862g (CgSNQ2) and CAGL0F02717g (CgPDH1) have been shown to play major role in the development of MDR phenotypes in clinical isolates and petite mutants of C. glabrata [58–61]. These three transporters are regulated by transcription factor PDR1 and their upregulation is linked to the azole resistance [24]. CAGL0F01419g (CgAUS1) is a sterol transporter and protects cells against azole antifungals in the presence of serum [62,63]. These C. glabrata genes showed sequence similarity with human ABCG members involved in exporting anti-cancerous drugs and cholesterol transport. Other members of PDR subfamily are poorly characterized in C. glabrata. However, their functions can be predicted based on sequence identity with PDR/ABCG members of other yeast species. For instance, CAGL0M07293g is an ortholog of S. cerevisiae PDR12 with 85% sequence identity, which is involved in organic acid transport [64], while CAGL0I08019g with 36% sequence identity to CDR6/ROA1 of C. albicans governs resistance to azoles [65]. The half transporter CAGL0L07744g shows 67% sequence identity with S. cerevisiae ADP1, the first identified half transporter belongs to the WBC family of Drosophila [66].
Others
Soluble ABC proteins that do not cluster into any specified subfamily has been kept under the category of others. In C. glabrata two proteins, CAGL0G05093g and CAGL0K12474g come into this category with two NBD and one NBD, respectively. CAGL0G05093g showed an orthologous relationship with uncharacterized protein in S. cerevisiae (YDR061W) and have 32% sequence identity with C. albicans MODF. CAGL0K12474g gene has orthologous relationship with CAF16 of S. cerevisiae which is known to be a part of CCR4-NOT regulatory complex involved in transcriptional control of gene regulation [67].
Chromosomal position and localization prediction
C. glabrata with haploid genome consists of 13 chromosomes (Chr A to Chr M) [18]. Chr M harbors maximum number of ABC protein encoding genes (4 genes) followed by Chr E, Chr G and Chr K, each possess 3 genes. Each of Chr C, Chr D, Chr F, Chr I and Chr L accommodate 2 genes. Each Chr A and Chr B reside only 1 gene, however, Chr H and Chr J do not contain any ABC protein coding gene (Fig 4A).
Subcellular localization (SCL) of a protein is important to elucidate the potential function in various cellular processes. It is anticipated that proteins localized in the same cellular compartment of different organisms could perform similar type of function. SCLs of ABC proteins of C. glabrata were analysed by using online software LocTree3. The results obtained suggested that most of the C. glabrata MDR/ABCB members are localized in mitochondrial membrane and MRP/ABCC members are localized in vacuolar membrane (VM). As expected, ALDp/ABCD members were predicted to be localized on peroxisomal membrane. ABC proteins of PDR/ABCG subfamily were predicted in plasma membrane (PM) except CAGL0L07744g, which was found to be localized on endoplasmic reticulum (ER) (Fig 4B). Previous reports supported our localization prediction as two of the known PDR/ABCG members, CAGL0M01760g (CgCDR1) and CAGL0F02717g (CgPDH1) were shown to be plasma membrane localized [68]. Notably, localization prediction varies by the use of different softwares. ABC proteins, CAGL0I08019g and CAGL0K00363g belonging to PDR/ABCG and MDR/ABCB subfamilies, respectively, were predicted to be localized at the nucleus by LocTree3 software, however, WoLF PSORT predicted these proteins localization at PM. WoLF PSORT predicted CAGL0G00242g (CgYOR1) and CAGL0L07744g localization to PM, while LocTree3 predicted in VM and ER membranes, respectively. The predicted localization of 18 ABC membrane proteins are depicted in Fig 4B, while soluble ABC proteins are predicted to be confined to the cytosol or nucleus are listed in S2 File.
Membrane localized ABC subfamily genes displayed variable response to drug exposure
Our long term goal is to unravel the role of membrane localized efflux pumps in development of MDR. Hence, for expression analysis, we selected 18 potential membrane localized members of the ABC superfamily. It is expected that expression level of genes may vary among strains with different genetic background and source of isolation. Therefore, in this study we evaluated the expression level of ABC transporter genes between the two strains of C. glabrata: a reference strain CBS138/ATCC2001 and a widely used clinical isolate BG2.
Initially, we tested the basal expression level of these gene under laboratory growth conditions. qRT-PCR analysis of the mid-log phage grown cells in YPD media at 30°C confirmed that all selected ABC transporter were transcribed under normal growth condition in both the strains. However, the degree of basal expression showed considerable variation in these strains. Since strain BG2 was an isolate from a patient with initial exposure to fluconazole treatment, expectedly, in comparison to CBS138/ATCC2001, its encoding transporter genes were upregulated at basal level (Fig 5). Therefore, after transient drug exposure, the ABC transporter genes of BG2 show lesser changes in their expression. But in CBS138/ATCC2001 strain, the transient drug induction yielded stronger response and comparatively showed higher changes in expression pattern of ABC genes in all tested condition (Fig 6A–6D).
Frequently, enhanced expression of several ABC superfamily genes was directly linked to the acquisition of drug resistance among different yeast species. Earlier, several reports demonstrated that in clinical MDR isolates of C. glabrata, ABC transporters such as CAGL0M01760g (CgCDR1), CAGL0I04862g (CgSNQ2) and CAGL0F02717g (CgPDH1) were highly expressed and their expression varied in laboratory strains during transient drug induction and environmental conditions [69,70]. For evaluating the role of ABC membrane proteins coding genes, we further tested expression of all selected ABC transporters followed by 60 min exposure to azoles (fluconazole, ketoconazole), echinocandin (caspofungin) and polyene (amphotericin B) drugs. The data obtained by qRT-PCR provided an interesting insight on to the expression pattern of ABC transporters under stress conditions. For instance, all the tested drugs exhibited differential expression pattern of membrane ABC superfamily genes, implying their role in the development of drug resistance phenotypes.
Among MDR members, basal expression of CAGL0K00363g was lowest, in both the strains. Notably, CAGL0K00363g ortholog in S. cerevisiae (STE6) is a dedicated pheromone transporter and its human homolog (ABCB1) mediated MDR in various chemotherapy resistant tumors by effluxing toxic compounds [71]. Although CAGL0K00363g was 1.7 fold upregulated in presence of both caspofungin and ketoconazole in BG2 strain, but in CBS138/ATCC2001 strain it was down regulated to 14.6 and 22.1 fold in presence these drugs. Most of the MDR genes in CBS138/ATCC2001 strain displayed down regulation following amphotericin B, caspofungin, and ketoconazole treatment but were up regulated in fluconazole exposed cells. Interestingly, in BG2 strain the expression level of other MDR members remained unchanged during fluconazole, amphotericin B and caspofungin inductions except CAGL0E00385g and CAGL0M13739g (CgATM1), wherein expression level was significantly higher followed by ketoconazole exposure (Fig 6D).
Among MRP subfamily members, basal expression level of CAGL0E03355g was low in both the strains. CAGL0G00242g (CgYOR1) was upregulated by azoles in CBS138//ATCC2001, while, in BG2 strain the expression level was down regulated by 1.5 fold following amphotericin B treatment. However, in case of ketoconazole exposed cells, it was 1.8 fold upregulated. CAGL0G00242g (CgYOR1) ortholog in S. cerevisiae (YOR1) has a well demonstrated role in pleiotropic drug resistance [72]. CAGL0C03289g (CgYBT1) displayed higher expression following drug treatment in both strains. While, CAGL0E03982g transcript level was significantly upregulated only in fluconazole treated BG2 cells, whereas in CBS138/ATCC2001 strain, it was upregulated by amphotericin B treatment only. CAGL0E03355g transcript level was significantly down regulated in both tested strains followed by most of the inducing conditions. Notably, human MRP family member ABCC1 is involved in multidrug resistance, especially during cancer and leukemia chemotherapy treatments [73] However, its ortholog CAGL0L06402g (CgYCF1) in C. glabrata does not respond to tested drug in BG2 strain but were significantly upregulated in case of amphotericin B and caspofungin exposed CBS138/ATCC2001 strain. Together, qRT-PCR analysis of MRP subfamily genes in C. glabrata similar to other yeast species do point to their involvement in drug detoxification.
Both ALDp members exhibited significantly higher expression at basal level in BG2 than in CBS138/ATCC2001. The expression level of ALDp members remained unresponsive to drug treatment in BG2. However, in CBS138/ATCC2001 strain CAGL0M02387g was significantly down regulated in ketoconazole and upregulated with other tested inducing conditions while CAGL0D00352g showed significant down regulation in fluconazole treatment.
Together, PDR subfamily member genes revealed constitutive expression, and they are the best responders to transient drug treatments. CAGL0M01760g (CgCDR1) and CAGL0F02717g (CgPDH1) have similar behavior with ketoconazole treatment in both the strains. The expression of CAGL0M07293g, an ortholog of S. cerevisiae PDR12 (weak acid transporter) was higher following ketoconazole treatment in both the strains. The low level of expression of CAGL0M07293g in fluconazole resistant isolates of C. glabrata was earlier recorded by Vermitsky et. al. [41], which could be consistent with the low expression in BG2 strain. In BG2 strain CAGL0M07293g gene behaved differently in different azoles, where an imidazole and a triazole yielded opposite response. CAGL0F02717g (CgPDH1) was down regulated in most of the treatment condition in both the strain. Based on homology with CaCDR1 and CaCDR2, it is reasonable to expect that CAGL0F02717g (CgPDH1) could be involved in phospholipid translocation and membrane lipid asymmetry maintenance [74]. As expected, fluconazole treatment induced CAGL0F01419g (CgAUS1) expression in both the strains. PDR members displayed varying degree of changes in expression, which strongly indicate their role in multi drug resistance.
Conclusion
The study presents a first comprehensive transportome analysis of ABC proteins in C. glabrata, which led to the identification of 25 ABC proteins, representing 0.479% of protein coding genes, distributed on 11 out of 13 chromosomes. The phylogenetic comparison with other fungal species clustered these ABC members into six major subfamilies: MDR/ABCB, MRP/ABCC, ALD/ABCD, RLI/ABCE, EF3/ABCF and PDR/ABCG. The constitutive expression of all the genes encoding putative membrane localized ABC members not only confirmed their genomic presence but also reflected their biological relevance. The exposure to drugs presented variable transcriptional response among ABC membrane proteins, nonetheless, it provided sufficient clue for their potential contribution in emerging clinical drug resistance in C. glabrata isolates. Of note, majority of members of subfamilies remain unexplored. The sequence identity of C. glabrata ABC proteins with other organism could provide a basis for functional characterization of these unexplored important proteins; however, our analysis could only predict their localization and putative function. Based on the information available in S. cerevisiae and other yeasts, most of the ABC transporter genes are non-essential and hence construction of homozygous knockouts (KOs) should be realtively easy. The analysis of KOs of each member is a way forward in dissecting their role in MDR, pathogenicity and virulence. The studies so far do suggest that some of the ABC members, particularly those belonging to PDR family (CgCDR1, CgPDH1 and CgSNQ2) have demonstrable role in developing drug resistance but considering the vast information about the role of ABC members in C. albicans and in other organisms, it is a long way before their physiological relevance of these ABC proteins could be unraveled.
Supporting information
Acknowledgments
The authors are grateful to Dr. Rupinder Kaur, CDFD, Hyderabad, India and Neeraj Chauhan, Public Health Research Institute Center, New Jersey Medical School–Rutgers, Newark, New Jersey for their kind gift of C. glabrata BG2 and CBS138/ATCC2001 strain respectively. The authors are also thankful to Dr. Ajay Kumar Pandey for English and grammatical correction of the manuscript.
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
The work has been supported in parts by grants to R.P. from the Department of Biotechnology DBT [No. BT/01/CEIB/10/III/02], DBT [No. BT/PR7392/MED/29/652/2012] and DBT [No. BT/PR14117/BRB/10/1420/2015] and in parts by grants to N.A.G. by DST Ramanujan Fellowship grant [SR/S2/RJN-07/2012], DBT grants [No. BT/PR10684/PBD/26/403/2013] and DBT [No. BT/PB/Centre/03/2011]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Glavinas H, Krajcsi P, Cserepes J, Sarkadi B. The role of ABC transporters in drug resistance, metabolism and toxicity. Curr Drug Deliv. United Arab Emirates; 2004;1: 27–42. [DOI] [PubMed] [Google Scholar]
- 2.Davidson AL, Dassa E, Orelle C, Chen J. Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems. Microbiol Mol Biol Rev. American Society for Microbiology (ASM); 2008;72: 317–364. 10.1128/MMBR.00031-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Wilkens S. Structure and mechanism of ABC transporters. F1000Prime Rep. 2015;7: 1–9. doi: 10.12703/P7-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Linton KJ, Higgins CF. Structure and function of ABC transporters: the ATP switch provides flexible control. Pflugers Arch. Germany; 2007;453: 555–567. 10.1007/s00424-006-0126-x [DOI] [PubMed] [Google Scholar]
- 5.Rai V, Gaur M, Shukla S, Shukla S, Ambudkar S V, Komath SS, et al. Conserved Asp327 of Walker B motif in the N-terminal Nucleotide Binding Domain (NBD-1) of Cdr1p of Candida albicans has acquired a new role in ATP hydrolysis. Biochemistry. 2006;45: 14726–14739. 10.1021/bi061535t [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Prasad R, Banerjee A, Khandelwal NK, Dhamgaye S. The ABCs of Candida albicans multidrug transporter Cdr1. Eukaryot Cell. 2015;14: EC.00137-15 10.1128/EC.00137-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gaur M, Choudhury D, Prasad R. Complete inventory of ABC proteins in human pathogenic yeast, Candida albicans. J Mol Microbiol Biotechnol. Switzerland; 2005;9: 3–15. 10.1159/000088141 [DOI] [PubMed] [Google Scholar]
- 8.ter Beek J, Guskov A, Slotboom DJ. Structural diversity of ABC transporters. J Gen Physiol. United States; 2014;143: 419–435. 10.1085/jgp.201411164 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Prasad R Dr, Rawal MK. Efflux pump proteins in antifungal resistance. Front Pharmacol. 2014;5 AUG: 1–13. 10.3389/fphar.2014.00001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wilkens S. Structure and mechanism of ABC transporters. F1000Prime Rep. England; 2015;7: 14 doi: 10.12703/P7-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res. United States; 2001;42: 1007–1017. [PubMed] [Google Scholar]
- 12.Verrier PJ, Bird D, Burla B, Dassa E, Forestier C, Geisler M, et al. Plant ABC proteins—a unified nomenclature and updated inventory. Trends Plant Sci. England; 2008;13: 151–159. 10.1016/j.tplants.2008.02.001 [DOI] [PubMed] [Google Scholar]
- 13.Annilo T, Chen Z-Q, Shulenin S, Costantino J, Thomas L, Lou H, et al. Evolution of the vertebrate ABC gene family: analysis of gene birth and death. Genomics. United States; 2006;88: 1–11. 10.1016/j.ygeno.2006.03.001 [DOI] [PubMed] [Google Scholar]
- 14.Kovalchuk A, Driessen AJM. Phylogenetic analysis of fungal ABC transporters. BMC Genomics. 2010;11: 177 10.1186/1471-2164-11-177 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Decottignies A, Goffeau A. Complete inventory of the yeast ABC proteins. Nat Genet. United States; 1997;15: 137–145. 10.1038/ng0297-137 [DOI] [PubMed] [Google Scholar]
- 16.Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. United States; 2007;20: 133–163. 10.1128/CMR.00029-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kaur R, Domergue R, Zupancic ML, Cormack BP. A yeast by any other name: Candida glabrata and its interaction with the host. Curr Opin Microbiol. England; 2005;8: 378–384. 10.1016/j.mib.2005.06.012 [DOI] [PubMed] [Google Scholar]
- 18.Dujon B, Sherman D, Fischer G, Durrens P, Casaregola S, Lafontaine I, et al. Genome evolution in yeasts. Nature. England; 2004;430: 35–44. 10.1038/nature02579 [DOI] [PubMed] [Google Scholar]
- 19.Oxman DA, Chow JK, Frendl G, Hadley S, Hershkovitz S, Ireland P, et al. Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern? J Antimicrob Chemother. England; 2010;65: 1460–1465. 10.1093/jac/dkq136 [DOI] [PubMed] [Google Scholar]
- 20.Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J. The ATP binding cassette transporter GeneCgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother. Am Soc Microbiol; 1999;43: 2753–2765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Sanglard D, Ischer F, Bille J. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob Agents Chemother. 2001;45: 1174–1183. 10.1128/AAC.45.4.1174-1183.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD, et al. Azole Antifungal Resistance in Candida albicans and Emerging Non- albicans Candida Species. 2017;7: 1–12. 10.3389/fmicb.2016.02173 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chemother. United States; 2005;49: 668–679. 10.1128/AAC.49.2.668-679.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Torelli R, Posteraro B, Ferrari S, La Sorda M, Fadda G, Sanglard D, et al. The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata. Mol Microbiol. 2008;68: 186–201. 10.1111/j.1365-2958.2008.06143.x [DOI] [PubMed] [Google Scholar]
- 25.Ben-Ami R, Zimmerman O, Finn T, Amit S, Novikov A, Wertheimer N, et al. Heteroresistance to Fluconazole Is a Continuously Distributed Phenotype among Candida glabrata Clinical Strains Associated with In Vivo Persistence. MBio. United States; 2016;7 10.1128/mBio.00655-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001;25: 402–408. 10.1006/meth.2001.1262 [DOI] [PubMed] [Google Scholar]
- 27.Prasad R, Khandelwal NK, Banerjee A. Yeast ABC transporters in lipid trafficking. Fungal Genet Biol. United States; 2016;93: 25–34. 10.1016/j.fgb.2016.05.008 [DOI] [PubMed] [Google Scholar]
- 28.Birchler JA, Veitia RA. The Gene Balance Hypothesis: implications for gene regulation, quantitative traits and evolution. New Phytol. 2010;186: 54–62. 10.1111/j.1469-8137.2009.03087.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Xiong J, Feng J, Yuan D, Zhou J, Miao W. Tracing the structural evolution of eukaryotic ATP binding cassette transporter superfamily. Sci Rep. The Author(s); 2015;5: 16724 Available: 10.1038/srep16724 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Khunweeraphong N, Stockner T, Kuchler K. The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion. Sci Rep. 2017;7: 13767 10.1038/s41598-017-11794-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Anjard C, Consortium the DS, Loomis WF. Evolutionary Analyses of ABC Transporters of Dictyostelium discoideum. Eukaryot Cell. American Society for Microbiology; 2002;1: 643–652. 10.1128/EC.1.4.643-652.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kuchler K, Sterne RE, Thorner J. Saccharomyces cerevisiae STE6 gene product: a novel pathway for protein export in eukaryotic cells. EMBO J. England; 1989;8: 3973–3984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kispal G, Csere P, Guiard B, Lill R. The ABC transport Atm1p is required for mitochondrial iron homeostasis. FEBS Lett. Federation of European Biochemical Societies; 1997;418: 346–350. 10.1016/S0014-5793(97)01414-2 [DOI] [PubMed] [Google Scholar]
- 34.Schwarzmuller T, Ma B, Hiller E, Istel F, Tscherner M, Brunke S, et al. Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes. PLoS Pathog. United States; 2014;10: e1004211 10.1371/journal.ppat.1004211 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Dean M, Allikmets R, Gerrard B, Stewart C, Kistler A, Shafer B, et al. Mapping and sequencing of two yeast genes belonging to the ATP- binding cassette superfamily. Yeast. 1994;10: 377–383. 10.1002/yea.320100310 [DOI] [PubMed] [Google Scholar]
- 36.Klein M, Burla B, Martinoia E. The multidrug resistance-associated protein (MRP/ABCC) subfamily of ATP-binding cassette transporters in plants. FEBS Lett. England; 2006;580: 1112–1122. 10.1016/j.febslet.2005.11.056 [DOI] [PubMed] [Google Scholar]
- 37.Jeong CB, Kim DH, Kang HM, Lee YH, Kim HS, Kim IC, et al. Genome-wide identification of ATP-binding cassette (ABC) transporters and their roles in response to polycyclic aromatic hydrocarbons (PAHs) in the copepod Paracyclopina nana. Aquat Toxicol. Elsevier B.V.; 2017;183: 144–155. 10.1016/j.aquatox.2016.12.022 [DOI] [PubMed] [Google Scholar]
- 38.Dermauw W, Van Leeuwen T. The ABC gene family in arthropods: comparative genomics and role in insecticide transport and resistance. Insect Biochem Mol Biol. England; 2014;45: 89–110. 10.1016/j.ibmb.2013.11.001 [DOI] [PubMed] [Google Scholar]
- 39.Cui Z, Hirata D, Tsuchiya E, Osada H, Miyakawa T. The multidrug resistance-associated protein (MRP) subfamily (Yrs1/Yor1) of Saccharomyces cerevisiae is important for the tolerance to a broad range of organic anions. J Biol Chem. United States; 1996;271: 14712–14716. [DOI] [PubMed] [Google Scholar]
- 40.Vernon RM, Chong PA, Lin H, Yang Z, Zhou Q, Aleksandrov AA, et al. Stabilization of a nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator yields insight into disease-causing mutations. J Biol Chem. United States; 2017;292: 14147–14164. 10.1074/jbc.M116.772335 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Vermitsky J-P, Earhart KD, Smith WL, Homayouni R, Edlind TD, Rogers PD. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Mol Microbiol. 2006;61: 704–722. 10.1111/j.1365-2958.2006.05235.x [DOI] [PubMed] [Google Scholar]
- 42.Tsai H-F, Sammons LR, Zhang X, Suffis SD, Su Q, Myers TG, et al. Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates. Antimicrob Agents Chemother. United States; 2010;54: 3308–3317. 10.1128/AAC.00535-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Johnson ZL, Chen J. Structural Basis of Substrate Recognition by the Multidrug Resistance Protein MRP1. Cell. United States; 2017;168: 1075–1085.e9. 10.1016/j.cell.2017.01.041 [DOI] [PubMed] [Google Scholar]
- 44.Ferrari S, Sanguinetti M, De Bernardis F, Torelli R, Posteraro B, Vandeputte P, et al. Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice. Antimicrob Agents Chemother. United States; 2011;55: 1852–1860. 10.1128/AAC.01271-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Theodoulou FL, Holdsworth M, Baker A. Peroxisomal ABC transporters. FEBS Lett. 2006;580: 1139–1155. 10.1016/j.febslet.2005.12.095 [DOI] [PubMed] [Google Scholar]
- 46.Morita M, Imanaka T. Peroxisomal ABC transporters: structure, function and role in disease. Biochim Biophys Acta. Netherlands; 2012;1822: 1387–1396. 10.1016/j.bbadis.2012.02.009 [DOI] [PubMed] [Google Scholar]
- 47.van Roermund CWT, Visser WF, Ijlst L, Waterham HR, Wanders RJA. Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid beta-oxidation. Biochim Biophys Acta. Netherlands; 2011;1811: 148–152. 10.1016/j.bbalip.2010.11.010 [DOI] [PubMed] [Google Scholar]
- 48.Shani N, Valle D. A Saccharomyces cerevisiae homolog of the human adrenoleukodystrophy transporter is a heterodimer of two half ATP-binding cassette transporters. Proc Natl Acad Sci U S A. 1996;93: 11901–11906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Pujol A, Ferrer I, Camps C, Metzger E, Hindelang C, Callizot N, et al. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum Mol Genet. England; 2004;13: 2997–3006. 10.1093/hmg/ddh323 [DOI] [PubMed] [Google Scholar]
- 50.Tian L, Song T, He R, Zeng Y, Xie W, Wu Q, et al. Genome-wide analysis of ATP-binding cassette (ABC) transporters in the sweetpotato whitefly, Bemisia tabaci. BMC Genomics. England; 2017;18: 330 10.1186/s12864-017-3706-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Dong J, Lai R, Nielsen K, Fekete CA, Qiu H, Hinnebusch AG. The essential ATP-binding cassette protein RLI1 functions in translation by promoting preinitiation complex assembly. J Biol Chem. United States; 2004;279: 42157–42168. 10.1074/jbc.M404502200 [DOI] [PubMed] [Google Scholar]
- 52.Khoshnevis S, Gross T, Rotte C, Baierlein C, Ficner R, Krebber H. The iron-sulphur protein RNase L inhibitor functions in translation termination. EMBO Rep. England; 2010;11: 214–219. 10.1038/embor.2009.272 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Schmidt P, Walker J, Selway L, Stead D, Yin Z, Enjalbert B, et al. Proteomic analysis of the pH response in the fungal pathogen Candida glabrata. Proteomics. Germany; 2008;8: 534–544. 10.1002/pmic.200700845 [DOI] [PubMed] [Google Scholar]
- 54.Nakayama H, Izuta M, Nagahashi S, Sihta EY, Sato Y, Yamazaki T, et al. A controllable gene-expression system for the pathogenic fungus Candida glabrata. Microbiology. England; 1998;144 (Pt 9: 2407–2415. 10.1099/00221287-144-9-2407 [DOI] [PubMed] [Google Scholar]
- 55.Vazquez de Aldana CR, Marton MJ, Hinnebusch AG. GCN20, a novel ATP binding cassette protein, and GCN1 reside in a complex that mediates activation of the eIF-2 alpha kinase GCN2 in amino acid-starved cells. EMBO J. 1995;14: 3184–99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Anjard C, Loomis WF. Evolutionary analyses of ABC transporters of Dictyostelium discoideum. Eukaryot Cell. United States; 2002;1: 643–652. 10.1128/EC.1.4.643-652.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Kolaczkowski M, Van der Rest M, Cybularz-Kolaczkowska A, Soumillion JP, Konings WN, Goffeau A. Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p. J Biol Chem. 1996;271: 31543–31548. 10.1074/jbc.271.49.31543 [DOI] [PubMed] [Google Scholar]
- 58.Miyazaki H, Miyazaki Y, Geber A, Parkinson T, Hitchcock C, Falconer DJ, et al. Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob Agents Chemother. United States; 1998;42: 1695–1701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Izumikawa K, Kakeya H, Tsai HF, Grimberg B, Bennett JE. Function of Candida glabrata ABC transporter gene, PDH1. Yeast. 2003;20: 249–261. 10.1002/yea.962 [DOI] [PubMed] [Google Scholar]
- 60.Brun S, Bergès T, Poupard P, Renier G, Chabasse D, Bouchara J, et al. Mechanisms of Azole Resistance in Petite Mutants of Candida glabrata Mechanisms of Azole Resistance in Petite Mutants of Candida glabrata. Society. 2004; 1788–1796. 10.1128/AAC.48.5.1788 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Whaley SG, Rogers PD. Azole Resistance in Candida glabrata. Curr Infect Dis Rep. Current Infectious Disease Reports; 2016;18: 19–21. 10.1007/s11908-016-0525-x [DOI] [PubMed] [Google Scholar]
- 62.Nagi M, Tanabe K, Nakayama H, Yamagoe S, Umeyama T, Oura T, et al. Serum cholesterol promotes the growth of Candida glabrata in the presence of fluconazole. J Infect Chemother. Elsevier; 2013;19: 138–143. 10.1007/s10156-012-0531-3 [DOI] [PubMed] [Google Scholar]
- 63.Nakayama H, Tanabe K, Bard M, Hodgson W, Wu S, Takemori D, et al. The Candida glabrata putative sterol transporter gene CgAUS1 protects cells against azoles in the presence of serum. J Antimicrob Chemother. 2007;60: 1264–1272. 10.1093/jac/dkm321 [DOI] [PubMed] [Google Scholar]
- 64.Piper P, Mahe Y, Thompson S, Pandjaitan R, Holyoak C, Egner R, et al. The pdr12 ABC transporter is required for the development of weak organic acid resistance in yeast. EMBO J. England; 1998;17: 4257–4265. 10.1093/emboj/17.15.4257 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Khandelwal NK, Chauhan N, Sarkar P, Esquivel BD, Coccetti P, Singh A, et al. Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6/ROA1 depends on TOR signaling. J Biol Chem. 2017; jbc.M117.807032 10.1074/jbc.M117.807032 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Rogers B, Decottignies a, Kolaczkowski M, Carvajal E, Balzi E, Goffeau a. The pleitropic drug ABC transporters from Saccharomyces cerevisiae. J Mol Microbiol Biotechnol. 2001;3: 207–214. [PubMed] [Google Scholar]
- 67.Liu HY, Chiang YC, Pan J, Chen J, Salvadore C, Audino DC, et al. Characterization of CAF4 and CAF16 Reveals a Functional Connection between the CCR4-NOT Complex and a Subset of SRB Proteins of the RNA Polymerase II Holoenzyme. J Biol Chem. 2001;276: 7541–7548. 10.1074/jbc.M009112200 [DOI] [PubMed] [Google Scholar]
- 68.Lamping E, Monk BC, Niimi K, Holmes AR, Tsao S, Tanabe K, et al. Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Eukaryot Cell. United States; 2007;6: 1150–1165. 10.1128/EC.00091-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Vale-Silva L, Ischer F, Leibundgut-Landmann S, Sanglard D. Gain-of-function mutations in PDR1, a regulator of antifungal drug resistance in Candida glabrata, control adherence to host cells. Infect Immun. United States; 2013;81: 1709–1720. 10.1128/IAI.00074-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Samaranayake YH, Cheung BPK, Wang Y, Yau JYY, Yeung KWS, Samaranayake LP. Fluconazole resistance in Candida glabrata is associated with increased bud formation and metallothionein production. J Med Microbiol. England; 2013;62: 303–318. 10.1099/jmm.0.044123-0 [DOI] [PubMed] [Google Scholar]
- 71.Wu C-P, Calcagno AM, Ambudkar S V. Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: Evaluation of current strategies. Curr Mol Pharmacol. 2008;1: 93–105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Klein C, Kuchler K, Valachovic M. ABC proteins in yeast and fungal pathogens. Essays Biochem. 2011;50: 101–19. 10.1042/bse0500101 [DOI] [PubMed] [Google Scholar]
- 73.Slomka M, Sobalska-Kwapis M, Korycka-Machala M, Bartosz G, Dziadek J, Strapagiel D. Genetic variation of the ABC transporter gene ABCC1 (Multidrug resistance protein 1-MRP1) in the Polish population. BMC Genet. England; 2015;16: 114 10.1186/s12863-015-0271-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Smriti Krishnamurthy S, Dixit BL, Gupta CM, Milewski S, Prasad R. ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators. Yeast. England; 2002;19: 303–318. 10.1002/yea.818 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.